Gene Bridges' licenses Red/ET to Daiichi Sankyo

Gene Bridges GmbH, a German recombineering company, says that Daiichi Sankyo of Tokyo, Japan, has completed a commercial license agreement for  the use of its Red/ET recombination technology, which is a method for  generating targeting vectors or modifying E. coli chromosomes.

According to the Heidelberg-based firm, Red/ET is a revolutionary method  for DNA engineering that allows cloning, subcloning and modification of  DNA at any chosen position. It permits precise engineering of DNA  molecules of any size, including very large ones such as BACs or the  E.coli chromosome.

Recombineering DNA using Red/ET has a number of advantages over  conventional methods, the firm noted. It works independent of  restriction sites, has no size limits or mutations and is rapid. Gene  Bridges is represented in Japan by the distribution partner Funakoshi.